0

Biopharmaceutical Analytical Testing Services Market by End-user and Geography - Forecast and Analysis 2022-2026

  • Published: Apr 2022
  • Pages: 120
  • SKU: IRTNTR40457
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The biopharmaceutical analytical testing services market share is expected to increase by USD 2.83 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 12.41%.

This biopharmaceutical analytical testing services market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers biopharmaceutical analytical testing services market segmentation by end-user (pharma and biotech companies and CROs) and geography (North America, Europe, APAC, South America, and Middle East and Africa). The biopharmaceutical analytical testing services market report also offers information on several market vendors, including Alphabet Inc., AMCS Group, Aptean Group of Companies, BluJay Solutions Inc., Caliper Corp., Dassault Systemes SE, Descartes Systems Group Inc., Environmental Systems Research Institute Inc., FLS GmbH, IFS World Operations AB, Microlise Group Plc, Nomadia, OptimoRoute Inc., ORTEC B.V, Prism Visual Software Inc., PTV Planung Transport Verkehr AG, Route4Me Inc., Routific Solutions Inc., Trimble Inc., Verizon Communications Inc., and Wise Systems Inc. among others.

What will the Biopharmaceutical Analytical Testing Services Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Biopharmaceutical Analytical Testing Services Market Size for the Forecast Period and Other Important Statistics

 

Biopharmaceutical Analytical Testing Services Market: Key Drivers, Trends, and Challenges

The advanced route optimization strengthens shippers, LSPs, and carriers is notably driving the biopharmaceutical analytical testing services market growth, although factors such as security concerns may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the biopharmaceutical analytical testing services industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Biopharmaceutical Analytical Testing Services Market Driver

One of the key factors driving growth in the biopharmaceutical analytical testing services market is the increase in demand for mAbs. The global mAbs market is growing because mAbs are used for immunotherapy to stimulate immune responses to treat diseases. R and D for antibodies against diseases like Ebola, rheumatoid arthritis, and cancers is carried out. Cancer drug-conjugated mAbs cleave at the tumor site to provide targeted treatments. The increased demand for personalized medicine is a major factor in the enhanced demand for monoclonal antibodies. mAbs are produced in pharmaceutical and biotechnology companies to fulfill their increased demand. Therefore, mAbs are subjected to several quality control tests like microbial tests, sterility tests, and dissolution tests to ensure the quality of the mAbs. Biopharmaceutical analytical testing services include product-related impurities information, structural characterization, and structural confirmation. Thus, the rise in demand for mAbs will increase the demand for biopharmaceutical analytical testing services.

Key Biopharmaceutical Analytical Testing Services Market Trend

The rise in investment in R and D is a biopharmaceutical analytical testing services market trend that is expected to have a positive impact in the coming years. The global expenditure on R and D is increasing constantly, and it increased by 3.21% in 2016. With the economies of developing countries rising faster than that of developed countries, these countries are expected to have an increased number of laboratories and research facilities set up during the forecast period. The rise in the number of testing and research facilities, particularly in the field of pharmaceuticals, will raise the demand for analytical testing services to develop biopharmaceutical drugs.

Key Biopharmaceutical Analytical Testing Services Market Challenge

The shortage of trained professionals will be a major challenge for the biopharmaceutical analytical testing services market during the forecast period. Analytical testing requires skilled personnel and appropriate training. Pharmaceutical and biotechnology manufacturing facilities and laboratories want to produce products in short time spans. Therefore, the lack of required skills leads to a high degree of non-compliance among laboratory professionals. Improper testing and analysis of analytical tests may lead to product failures as they may not meet the regulatory requirements. Companies incur losses when products do not meet the regulatory requirements, and it becomes impossible to relaunch the drug or revise testing procedures. The shortage of trained laboratory professionals is a global concern. The lack of recognition of the profession and lack of required knowledge about the importance of laboratory professionals are a few other factors that contribute shortage of trained personnel. This shortage of trained professionals is expected to continue during the forecast period thereby, offsetting the growth of the market.

This biopharmaceutical analytical testing services market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global biopharmaceutical analytical testing services market as a part of the global life sciences tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the biopharmaceutical analytical testing services market during the forecast period.

Who are the Major Biopharmaceutical Analytical Testing Services Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Alphabet Inc.
  • AMCS Group
  • Aptean Group of Companies
  • BluJay Solutions Inc.
  • Caliper Corp.
  • Dassault Systemes SE
  • Descartes Systems Group Inc.
  • Environmental Systems Research Institute Inc.
  • FLS GmbH
  • IFS World Operations AB
  • Microlise Group Plc
  • Nomadia
  • OptimoRoute Inc.
  • ORTEC B.V
  • Prism Visual Software Inc.
  • PTV Planung Transport Verkehr AG
  • Route4Me Inc.
  • Routific Solutions Inc.
  • Trimble Inc.
  • Verizon Communications Inc.
  • Wise Systems Inc.

 

This statistical study of the biopharmaceutical analytical testing services market encompasses successful business strategies deployed by the key vendors. The biopharmaceutical analytical testing services market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Curia Inc.- The company offers biopharmaceutical analytical testing services that help in performing USP, BP, EP, and JP raw materials identity testing and offering a complete compendial testing solution, under the brand name of Curia.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The biopharmaceutical analytical testing services market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Biopharmaceutical Analytical Testing Services Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the biopharmaceutical analytical testing services market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Biopharmaceutical Analytical Testing Services Market?

For more insights on the market share of various regions Request for a FREE sample now!

33% of the market’s growth will originate from North America during the forecast period. The US is the key market for biopharmaceutical analytical testing services in North America. Market growth in this region will be faster than the growth of the market in the European, MEA and South American regions.

The US and Canada will be the largest revenue contributing countries in the region as stable economies and strong infrastructure supports the launch of new drugs or biopharmaceuticals. This will facilitate the biopharmaceutical analytical testing services market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 affected the economies of various countries in North America, especially the US. The outbreak had a slight negative impact on the biopharmaceutical analytical testing services market in the region. A rise in the number of COVID-19 cases in the first quarter of 2021 led to the imposition of partial lockdowns in several countries, including Canada and Mexico. However, by the second half of 2020, lockdown restrictions in various countries were lifted to some extent, which allowed the movement of people and led to the resumption of wet laboratory work. Thus, the resumption of life sciences tools and service operations will drive the demand for biopharmaceutical analytical testing services in North America, which, in turn, will drive the regional market during the forecast period.

What are the Revenue-generating End-user Segments in the Biopharmaceutical Analytical Testing Services Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The biopharmaceutical analytical testing services market share growth by the pharma and biotech companies segment will be significant during the forecast period. As the costs required to develop and commercialize drugs are high, companies constantly monitor factors like purity, safety, and efficacy of drugs to prevent losses. Hence, constant monitoring is required to check factors such as purity, safety, and efficacy of drugs. Analytical testing is essential to define the biological potency of molecules. Therefore, the increasing need and importance of analytical testing are encouraging the growth of the market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the biopharmaceutical analytical testing services market size and actionable market insights on post COVID-19 impact on each segment.

 

Biopharmaceutical Analytical Testing Services Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 12.41%

Market growth 2022-2026

$ 2.83 billion

Market structure

Fragmented

YoY growth (%)

14.97

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 33%

Key consumer countries

US, China, Japan, UK, and Germany

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Alphabet Inc., AMCS Group, Aptean Group of Companies, BluJay Solutions Inc., Caliper Corp., Dassault Systemes SE, Descartes Systems Group Inc., Environmental Systems Research Institute Inc., FLS GmbH, IFS World Operations AB, Microlise Group Plc, Nomadia, OptimoRoute Inc., ORTEC B.V, Prism Visual Software Inc., PTV Planung Transport Verkehr AG, Route4Me Inc., Routific Solutions Inc., Trimble Inc., Verizon Communications Inc., and Wise Systems Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Biopharmaceutical Analytical Testing Services Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive biopharmaceutical analytical testing services market growth during the next five years
  • Precise estimation of the biopharmaceutical analytical testing services market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the biopharmaceutical analytical testing services industry across North America, Europe, APAC, South America, and Middle East and Africa
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of biopharmaceutical analytical testing services market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 01: Parent market
    • Exhibit 02: Market characteristics
  • 2.2 Value chain analysis
    • Exhibit 03: Value chain analysis: Life sciences tools and services

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 04: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 05: Market segments
  • 3.3 Market size 2020
    • 3.4 Market outlook: Forecast for 2020 - 2025
      • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
      • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 08: Five forces analysis 2020 & 2025
    • 4.2 Bargaining power of buyers
      • Exhibit 09: Bargaining power of buyers
    • 4.3 Bargaining power of suppliers
      • Exhibit 10: Bargaining power of suppliers
    • 4.4 Threat of new entrants
      • Exhibit 11: Threat of new entrants
    • 4.5 Threat of substitutes
      • Exhibit 12: Threat of substitutes
    • 4.6 Threat of rivalry
      • Exhibit 13: Threat of rivalry
    • 4.7 Market condition
      • Exhibit 14: Market condition - Five forces 2020

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • 5.2 Comparison by End-user
        • Exhibit 16: Comparison by End-user
      • 5.3 Pharma and biotech companies - Market size and forecast 2020-2025
        • Exhibit 17: Pharma and biotech companies - Market size and forecast 2020-2025 ($ million)
        • Exhibit 18: Pharma and biotech companies - Year-over-year growth 2020-2025 (%)
      • 5.4 CROs - Market size and forecast 2020-2025
        • Exhibit 19: CROs - Market size and forecast 2020-2025 ($ million)
        • Exhibit 20: CROs - Year-over-year growth 2020-2025 (%)
      • 5.5 Market opportunity by End-user
        • Exhibit 21: Market opportunity by End-user

      6 Customer landscape

      • 6.1 Customer landscape
        • Exhibit 22: Customer landscape

      7 Geographic Landscape

      • 7.1 Geographic segmentation
        • Exhibit 23: Market share by geography 2020-2025 (%)
      • 7.2 Geographic comparison
        • Exhibit 24: Geographic comparison
      • 7.3 North America - Market size and forecast 2020-2025
        • Exhibit 25: North America - Market size and forecast 2020-2025 ($ million)
        • Exhibit 26: North America - Year-over-year growth 2020-2025 (%)
      • 7.4 Europe - Market size and forecast 2020-2025
        • Exhibit 27: Europe - Market size and forecast 2020-2025 ($ million)
        • Exhibit 28: Europe - Year-over-year growth 2020-2025 (%)
      • 7.5 APAC - Market size and forecast 2020-2025
        • Exhibit 29: APAC - Market size and forecast 2020-2025 ($ million)
        • Exhibit 30: APAC - Year-over-year growth 2020-2025 (%)
      • 7.6 South America - Market size and forecast 2020-2025
        • Exhibit 31: South America - Market size and forecast 2020-2025 ($ million)
        • Exhibit 32: South America - Year-over-year growth 2020-2025 (%)
      • 7.7 MEA - Market size and forecast 2020-2025
        • Exhibit 33: MEA - Market size and forecast 2020-2025 ($ million)
        • Exhibit 34: MEA - Year-over-year growth 2020-2025 (%)
      • 7.8 Key leading countries
        • Exhibit 35: Key leading countries
      • 7.9 Market opportunity by geography
        • Exhibit 36: Market opportunity by geography ($ million)

      8 Drivers, Challenges, and Trends

      • 8.1 Market drivers
        • 8.2 Market challenges
          • Exhibit 37: Impact of drivers and challenges
        • 8.3 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • Exhibit 38: Vendor landscape
          • 9.2 Landscape disruption
            • Exhibit 39: Landscape disruption
            • Exhibit 40: Industry risks

          10 Vendor Analysis

          • 10.1 Vendors covered
            • Exhibit 41: Vendors covered
          • 10.2 Market positioning of vendors
            • Exhibit 42: Market positioning of vendors
          • 10.3 Boston Analytical
            • Exhibit 43: Boston Analytical - Overview
            • Exhibit 44: Boston Analytical - Product and service
            • Exhibit 45: Boston Analytical - Key offerings
          • 10.4 Catalent Inc.
            • 10.5 Charles River Laboratories International Inc.
              • Exhibit 51: Charles River Laboratories International Inc. - Overview
              • Exhibit 52: Charles River Laboratories International Inc. - Business segments
              • Exhibit 53: Charles River Laboratories International Inc. - Key news
              • Exhibit 54: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 55: Charles River Laboratories International Inc. - Segment focus
            • 10.6 Eurofins Scientific SE
              • Exhibit 56: Eurofins Scientific SE - Overview
              • Exhibit 57: Eurofins Scientific SE - Business segments
              • Exhibit 58: Eurofins Scientific SE - Key offerings
              • Exhibit 59: Eurofins Scientific SE - Segment focus
            • 10.7 Intertek Group Plc
              • Exhibit 60: Intertek Group Plc - Overview
              • Exhibit 61: Intertek Group Plc - Business segments
              • Exhibit 62: Intertek Group Plc - Key news
              • Exhibit 63: Intertek Group Plc - Key offerings
              • Exhibit 64: Intertek Group Plc - Segment focus
            • 10.8 Merck KGaA
              • Exhibit 65: Merck KGaA - Overview
              • Exhibit 66: Merck KGaA - Business segments
              • Exhibit 67: Merck KGaA - Key offerings
              • Exhibit 68: Merck KGaA - Segment focus
            • 10.9 SGS SA
              • Exhibit 69: SGS SA - Overview
              • Exhibit 70: SGS SA - Business segments
              • Exhibit 71: SGS SA - Key news
              • Exhibit 72: SGS SA - Key offerings
              • Exhibit 73: SGS SA - Segment focus
            • 10.10 Solvias AG
              • Exhibit 74: Solvias AG - Overview
              • Exhibit 75: Solvias AG - Product and service
              • Exhibit 76: Solvias AG - Key offerings
            • 10.11 STERIS Plc
              • Exhibit 77: STERIS Plc - Overview
              • Exhibit 78: STERIS Plc - Business segments
              • Exhibit 79: STERIS Plc - Key offerings
              • Exhibit 80: STERIS Plc - Segment focus
            • 10.12 West Pharmaceutical Services Inc.
              • Exhibit 81: West Pharmaceutical Services Inc. - Overview
              • Exhibit 82: West Pharmaceutical Services Inc. - Business segments
              • Exhibit 83: West Pharmaceutical Services Inc. - Key news
              • Exhibit 84: West Pharmaceutical Services Inc. - Key offerings
              • Exhibit 85: West Pharmaceutical Services Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Currency conversion rates for US$
                • Exhibit 86: Currency conversion rates for US$
              • 11.3 Research methodology
                • Exhibit 87: Research Methodology
                • Exhibit 88: Validation techniques employed for market sizing
                • Exhibit 89: Information sources
              • 11.4 List of abbreviations
                • Exhibit 90: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The biopharmaceutical analytical testing services market growth will increase by $2725.53 million during 2021-2025.
              The biopharmaceutical analytical testing services market is expected to grow at a CAGR of 13.39% during 2021-2025.
              Technavio has segmented the biopharmaceutical analytical testing services market by end user (Pharma and biotech companies and CROs) and geographic (North America, Europe, APAC, South America, Middle East and Africa, North America, Europe, APAC, South America, and MEA).
              Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group Plc, Merck KGaA, SGS SA, Solvias AG, STERIS Plc, West Pharmaceutical Services Inc. are a few of the key vendors in the biopharmaceutical analytical testing services market.
              North America will register the highest growth rate of 32.21% among the other regions. Therefore, the biopharmaceutical analytical testing services market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the biopharmaceutical analytical testing services market growth are:
              • Increase in demand for mAbs
              • Rise in investment in R&D
              The biopharmaceutical analytical testing services market vendors should focus on grabbing business opportunities from the pharma and biotech companies segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>